Miso Park

624 total citations
37 papers, 445 citations indexed

About

Miso Park is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Miso Park has authored 37 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Oncology. Recurrent topics in Miso Park's work include Phagocytosis and Immune Regulation (4 papers), Cancer-related gene regulation (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Miso Park is often cited by papers focused on Phagocytosis and Immune Regulation (4 papers), Cancer-related gene regulation (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Miso Park collaborates with scholars based in South Korea, United States and Puerto Rico. Miso Park's co-authors include Keon Wook Kang, Wilfred Chen, Jong-Duk Kim, Kwang Se Lee, Qing Sun, Fang Liu, Matthew P. DeLisa, Shen‐Long Tsai, Sung‐Chul Lim and Chan Woo Park and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Miso Park

34 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miso Park South Korea 12 179 78 67 66 60 37 445
Min Wan China 9 235 1.3× 107 1.4× 77 1.1× 31 0.5× 72 1.2× 24 575
Soo Kyung Jeong South Korea 14 212 1.2× 207 2.7× 35 0.5× 85 1.3× 91 1.5× 27 606
Rachna Verma India 14 141 0.8× 106 1.4× 86 1.3× 13 0.2× 74 1.2× 31 484
Michał M. Godlewski Poland 17 197 1.1× 27 0.3× 38 0.6× 17 0.3× 63 1.1× 40 620
Lili Bao China 13 300 1.7× 32 0.4× 133 2.0× 44 0.7× 11 0.2× 27 716
Sixuan Li China 12 358 2.0× 47 0.6× 84 1.3× 31 0.5× 34 0.6× 48 619
Lifeng Zeng China 14 332 1.9× 31 0.4× 259 3.9× 55 0.8× 39 0.7× 17 495
Mengmeng Liu China 12 290 1.6× 13 0.2× 124 1.9× 32 0.5× 16 0.3× 26 403
Qiumei Wu China 8 164 0.9× 28 0.4× 104 1.6× 41 0.6× 19 0.3× 12 434
Barry O’Hagan United Kingdom 12 135 0.8× 12 0.2× 101 1.5× 51 0.8× 15 0.3× 22 422

Countries citing papers authored by Miso Park

Since Specialization
Citations

This map shows the geographic impact of Miso Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miso Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miso Park more than expected).

Fields of papers citing papers by Miso Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miso Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miso Park. The network helps show where Miso Park may publish in the future.

Co-authorship network of co-authors of Miso Park

This figure shows the co-authorship network connecting the top 25 collaborators of Miso Park. A scholar is included among the top collaborators of Miso Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miso Park. Miso Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mallett, Corey P., et al.. (2025). Leveraging novel CD38 targeted antibody-drug-conjugates for the treatment of multiple myeloma. Blood. 146(Supplement 1). 2161–2161.
2.
Park, Jaewoo, Baskaran Purushothaman, Sera Hong, et al.. (2024). GRP78 blockade overcomes acquired resistance to EGFR-tyrosine kinase inhibitors in non-small cell lung cancer. Life Sciences. 348. 122681–122681. 6 indexed citations
3.
Kim, Joonki, Hong Ryul Ahn, Y Kim, et al.. (2024). Phytotherapeutic BS012 and Its Active Component Ameliorate Allergic Asthma via Inhibition of Th2-Mediated Immune Response and Apoptosis. Biomolecules & Therapeutics. 32(6). 744–758.
4.
Park, Miso & Ji Won Kim. (2024). Updates on the mechanisms of toxicities associated with monoclonal antibodies targeting growth factor signaling and immune cells in cancer. Toxicological Research. 40(3). 335–348. 2 indexed citations
5.
Kim, Myung Jun, et al.. (2024). Prevention of radiotherapy-induced pro-tumorigenic microenvironment by SFK inhibitors. Theranostics. 15(3). 875–893. 2 indexed citations
6.
Park, Jaewoo, Miso Park, Myung Jun Kim, et al.. (2024). Therapeutic strategy using novel RET/YES1 dual-target inhibitor in lung cancer. Biomedicine & Pharmacotherapy. 171. 116124–116124. 2 indexed citations
7.
Park, Miso, Magali Pederzoli-Ribeil, Uğur Eskiocak, et al.. (2023). XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer. Journal for ImmunoTherapy of Cancer. 11(12). e007785–e007785. 8 indexed citations
8.
Kuo, Cheng-Fu, Kurt J. Jenkins, Wen-Chung Chang, et al.. (2022). Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cells. Journal for ImmunoTherapy of Cancer. 10(6). e003752–e003752. 7 indexed citations
9.
Kim, Soo Jin, Jaewoo Park, Miso Park, et al.. (2022). CKD-516 potentiates the anti-cancer activity of docetaxel against epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer. Toxicological Research. 39(1). 61–69. 1 indexed citations
10.
Park, Miso, Ji Won Kim, Kyu Min Kim, et al.. (2021). Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance. Cancer Research. 81(13). 3539–3553. 15 indexed citations
11.
Park, Miso, et al.. (2021). The Characteristics of the Compositions and Spatial Distributions of Submerged Marine Debris in the East Sea. Journal of the Korean Society of Marine Environment and Safety. 27(2). 295–307.
12.
Kim, Ji Won, et al.. (2021). Anti-metastatic effect of GV1001 on prostate cancer cells; roles of GnRHR-mediated Gαs-cAMP pathway and AR-YAP1 axis. Cell & Bioscience. 11(1). 191–191. 7 indexed citations
13.
Park, Miso, Ji‐Eun Kim, Jin‐Hee Park, et al.. (2019). Involvement of the P2X7 receptor in the migration and metastasis of tamoxifen-resistant breast cancer: effects on small extracellular vesicles production. Scientific Reports. 9(1). 11587–11587. 47 indexed citations
14.
Park, Miso & Keon Wook Kang. (2019). Phosphatidylserine receptor-targeting therapies for the treatment of cancer. Archives of Pharmacal Research. 42(7). 617–628. 30 indexed citations
15.
Park, Sehee, Ilseob Lee, Jin Il Kim, et al.. (2016). Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A(H7N9) virus in guinea pigs. Biochemical and Biophysical Research Communications. 479(2). 192–197. 15 indexed citations
16.
Lee, Kwang Se, Miso Park, Jang Myoun Ko, & Jong-Duk Kim. (2016). Electrochemical properties of multi-walled carbon nanotubes treated with nitric acid for a supercapacitor electrode. Colloids and Surfaces A Physicochemical and Engineering Aspects. 506. 664–669. 20 indexed citations
17.
18.
Park, Miso, Qing Sun, Fang Liu, Matthew P. DeLisa, & Wilfred Chen. (2014). Positional Assembly of Enzymes on Bacterial Outer Membrane Vesicles for Cascade Reactions. PLoS ONE. 9(5). e97103–e97103. 65 indexed citations
19.
Tsai, Shen‐Long, Miso Park, & Wilfred Chen. (2012). Size‐modulated synergy of cellulase clustering for enhanced cellulose hydrolysis. Biotechnology Journal. 8(2). 257–261. 33 indexed citations
20.
Park, Miso, et al.. (2006). Characterization of styrene catabolic genes of Pseudomonas putida SN1 and construction of a recombinant Escherichia coli containing styrene monooxygenase gene for the production of (S)-styrene oxide. Journal of Microbiology and Biotechnology. 16(7). 1032–1040. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min Wan Breakdown of academic impact, for papers by Soo Kyung Jeong Breakdown of academic impact, for papers by Rachna Verma Breakdown of academic impact, for papers by Michał M. Godlewski Breakdown of academic impact, for papers by Lili Bao Breakdown of academic impact, for papers by Sixuan Li Breakdown of academic impact, for papers by Lifeng Zeng Breakdown of academic impact, for papers by Mengmeng Liu Breakdown of academic impact, for papers by Qiumei Wu Breakdown of academic impact, for papers by Barry O’Hagan
Rankless by CCL
2026